Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Study to Investigate the Effect of Bupivacaine Liposomal Injectable Suspension on Hospital Costs, Length of Stay, and Discharge Status in Patients Undergoing Total Knee Arthroplasty at High Use Institutions

Next Previous
Trial Profile

A Study to Investigate the Effect of Bupivacaine Liposomal Injectable Suspension on Hospital Costs, Length of Stay, and Discharge Status in Patients Undergoing Total Knee Arthroplasty at High Use Institutions

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 09 Dec 2018

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Bupivacaine (Primary)
  • Indications Postoperative pain
  • Focus Therapeutic Use

Most Recent Events

  • 09 Dec 2018 New trial record
  • 27 Nov 2018 According to a Pacira Pharmaceuticals media release, results of this study were published in The Journal of Medical Economics.
  • 27 Nov 2018 New results from this study presented in a Pacira Pharmaceuticals media release.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top